4.5 (617) · $ 13.50 · In stock
Frontiers miR-34 – a microRNA replacement therapy is headed to
MicroRNA-34a is dispensable for p53 function as teratogenesis
CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in
MicroRNA-34a: the bad guy in age-related vascular diseases
MicroRNA-34a: the bad guy in age-related vascular diseases
MiR-34a and miR-34b/c have different effects on target gene
Clinical and histopathologic data of rhabdomyosarcoma tumor samples
Role of miR‑34 in gastric cancer: From bench to bedside (Review)
Expression of the miR-34 family. a Distribution of the miR-34s in
MicroRNAs mediate precise control of spinal interneuron